Lanzer G, Mayr W R
Department für Transfusionsmedizin und Immunhämatologie, Chirurgische Universitätsklinik Graz, Osterreich.
Anaesthesist. 1995 Mar;44(3):143-6. doi: 10.1007/s001010050140.
The safety of blood and blood components is an important aspect of transfusion medicine. Even if absolute safety of blood products cannot be achieved, this goal has come closer due to significant improvements. These include: (1) exact donor registration; (2) component preparation according to legal requirements and GMP guidelines; (3) determination of all relevant diagnostic parameters according to GMP/GLP guidelines; (4) adequate storage of products; and (5) and often underestimated parameter ensuring safety, strict guidelines for the use of blood products in the treatment of patients. Some of the results of the first Graz Consensus Conference on Transfusion Medicine are presented.
血液及血液成分的安全性是输血医学的一个重要方面。即便无法实现血液制品的绝对安全,但由于显著的改进,这一目标已越来越接近。这些改进包括:(1)准确的献血者登记;(2)根据法律要求和药品生产质量管理规范(GMP)指南进行成分制备;(3)按照GMP/GLP(良好实验室规范)指南确定所有相关诊断参数;(4)对产品进行充分储存;以及(5)一个常常被低估但能确保安全的因素,即在治疗患者时使用血液制品的严格指南。本文介绍了第一届格拉茨输血医学共识会议的一些成果。